Emergent BioSolutions EBS
NYSE EBS
$4.82 -0.07 (-1.43%)
At close: Aug 20, 2026 · 4:00 PM EDT

Emergent BioSolutions (EBS) Gross Profit (2011 - 2026)

Emergent BioSolutions (EBS) posted quarterly Gross Profit of $84.1 million for Q1 2026, down 37.1% year-over-year from $133.7 million in Q1 2025, and up 31.82% quarter-over-quarter from $63.8 million in Q4 2025.

Emergent BioSolutions (EBS) Gross Profit (2011 - 2026) Analysis & Trends

Emergent BioSolutions' Gross Profit history runs 16 years deep, the most recent figure standing at $84.1 million for Q1 2026.

  • In Q1 2026, Gross Profit fell 37.1% year-over-year to $84.1 million; the TTM figure through Mar 2026 stood at $367.1 million (down 3.8% YoY), while the FY2025 annual figure was $416.7 million, up 15.02% from the prior year.
  • Gross Profit for Q1 2026 stood at $84.1 million, up from $63.8 million in the prior quarter.
  • The five-year high for Gross Profit was $224.5 million in Q1 2022, with the low at $11.4 million in Q1 2023.
  • The 5-year median for Gross Profit is $113.7 million (2023), against an average of $118.2 million.
  • The sharpest annual moves came in 2023 and 2024: Gross Profit slumped 94.92% in 2023, then soared 1266.67% in 2024.
  • Emergent BioSolutions' Gross Profit stood at $162.9 million in 2022, then sank by 43.83% to $91.5 million in 2023, then slipped by 16.17% to $76.7 million in 2024, then fell by 16.82% to $63.8 million in 2025, then soared by 31.82% to $84.1 million in 2026.
  • Business Quant data shows EBS's Gross Profit at $84.1 million in Q1 2026, $63.8 million in Q4 2025, and $145.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.83 Bn 42.86 Bn -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn -
10 Emergent BioSolutions 251.81 Mn 110.91 Mn 137.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 137.20 Mn
Jun 30, 2026 137.20 Mn
Mar 31, 2026 84.10 Mn
Mar 31, 2026 84.10 Mn
Dec 31, 2025 63.80 Mn
Dec 31, 2025 63.80 Mn
Sep 30, 2025 145.20 Mn
Sep 30, 2025 145.20 Mn
Jun 30, 2025 74.00 Mn
Jun 30, 2025 74.00 Mn
Mar 31, 2025 133.70 Mn
Mar 31, 2025 133.70 Mn
Dec 31, 2024 76.70 Mn
Dec 31, 2024 76.70 Mn
Sep 30, 2024 171.20 Mn
Sep 30, 2024 171.20 Mn
Mar 31, 2024 155.80 Mn
Mar 31, 2024 155.80 Mn
Dec 31, 2023 91.50 Mn
Dec 31, 2023 91.50 Mn